Recently, GPR174, a seven-transmembrane G protein-coupled receptor, was identified to be mainly expressed on immune cells such as T/B cells (22) and reported as a risk factor for subcutaneous metastases (23), Graves’ disease (24), and autoimmune Addison’s disease (25). Here, GPR174 is linked to Graves disease.